TELA Bio Statistics

Total Valuation

TELA Bio has a market cap or net worth of $31.59 million. The enterprise value is $49.83 million.

Market Cap	31.59M
Enterprise Value	49.83M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

TELA Bio has 44.77 million shares outstanding. The number of shares has increased by 48.21% in one year.

Current Share Class	44.77M
Shares Outstanding	44.77M
Shares Change (YoY)	+48.21%
Shares Change (QoQ)	+10.78%
Owned by Insiders (%)	7.47%
Owned by Institutions (%)	22.90%
Float	20.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.39
Forward PS	0.35
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.61

Current Ratio	3.61
Quick Ratio	2.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.56

Financial Efficiency

Return on equity (ROE) is -616.62% and return on invested capital (ROIC) is -37.13%.

Return on Equity (ROE)	-616.62%
Return on Assets (ROA)	-28.72%
Return on Invested Capital (ROIC)	-37.13%
Return on Capital Employed (ROCE)	-64.94%
Weighted Average Cost of Capital (WACC)	9.42%
Revenue Per Employee	$370,706
Profits Per Employee	-$182,752
Employee Count	218
Asset Turnover	1.10
Inventory Turnover	2.03

Taxes

In the past 12 months, TELA Bio has paid $238,000 in taxes.

Income Tax	238,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.86% in the last 52 weeks. The beta is 1.31, so TELA Bio's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-61.86%
50-Day Moving Average	0.86
200-Day Moving Average	1.03
Relative Strength Index (RSI)	37.68
Average Volume (20 Days)	123,708

Short Selling Information

The latest short interest is 302,880, so 0.68% of the outstanding shares have been sold short.

Short Interest	302,880
Short Previous Month	748,090
Short % of Shares Out	0.68%
Short % of Float	1.51%
Short Ratio (days to cover)	2.61

Income Statement

In the last 12 months, TELA Bio had revenue of $80.81 million and -$39.84 million in losses. Loss per share was -$0.80.

Revenue	80.81M
Gross Profit	54.73M
Operating Income	-33.81M
Pretax Income	-39.60M
Net Income	-39.84M
EBITDA	-32.80M
EBIT	-33.81M
Loss Per Share	-$0.80

Full Income Statement

Balance Sheet

The company has $39.54 million in cash and $57.79 million in debt, giving a net cash position of -$18.25 million or -$0.41 per share.

Cash & Cash Equivalents	39.54M
Total Debt	57.79M
Net Cash	-18.25M
Net Cash Per Share	-$0.41
Equity (Book Value)	-5.20M
Book Value Per Share	-0.12
Working Capital	46.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.66 million and capital expenditures -$535,000, giving a free cash flow of -$30.20 million.

Operating Cash Flow	-29.66M
Capital Expenditures	-535,000
Depreciation & Amortization	1.01M
Net Borrowing	17.58M
Free Cash Flow	-30.20M
FCF Per Share	-$0.67

Full Cash Flow Statement

Margins

Gross margin is 67.72%, with operating and profit margins of -41.84% and -49.30%.

Gross Margin	67.72%
Operating Margin	-41.84%
Pretax Margin	-49.00%
Profit Margin	-49.30%
EBITDA Margin	-40.59%
EBIT Margin	-41.84%
FCF Margin	n/a

Dividends & Yields

TELA Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.21%
Shareholder Yield	-48.21%
Earnings Yield	-126.13%
FCF Yield	-95.61%

Analyst Forecast

The average price target for TELA Bio is $2.25, which is 218.88% higher than the current price. The consensus rating is "Buy".

Price Target	$2.25
Price Target Difference	218.88%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (3Y)	9.99%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TELA Bio has an Altman Z-Score of -7.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.42
Piotroski F-Score	3